New nanoparticles can perform gene editing in the lungs, MIT News

A new type of nanoparticle can be administered to the lungs, where it can deliver messenger RNA encoding useful proteins. Researchers hope to use them to develop new treatments for cystic fibrosis and other lung diseases.

The NIH Somatic Cell Genome Editing program

Lung SORT LNPs enable precise homology-directed repair mediated CRISPR/Cas genome correction in cystic fibrosis models

Advancements in Lipid Nanoparticles for Targeted Gene Therapy in the Lungs

Simple Paper Test Could Enable Early Cancer Diagnosis

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing

New Nanoparticles Carrying mRNA Can Perform In-Lung Gene Editing

Can This New Technology Catch Lung Cancer in Its Earliest Stages?

Scientists discover a new kind of cell death linked to copper

Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing